2.4 ML durvalumab 50 MG/ML Injection [Imfinzi]

RxCUI
1919512
RxNorm name
2.4 ML durvalumab 50 MG/ML Injection [Imfinzi]
Display name
2.4 ML durvalumab 50 MG/ML Injection [Imfinzi]
Full name
2.4 ML durvalumab 50 MG/ML Injection [Imfinzi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761069Imfinzidurvalumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IMFINZIDURVALUMABAstraZeneca Pharmaceuticals LP8baba4ea-2855-42fa-9bd9-5a7548d4cec32026-05-28Warnings, Adverse reactionsExact identifier
rxcui: 1919512

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8baba4ea-2855-42fa-9bd9-5a7548d4cec32.4 ML durvalumab 50 MG/ML Injection [Imfinzi]SBD32These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 201720251125
8baba4ea-2855-42fa-9bd9-5a7548d4cec3IMFINZI 120 MG per 2.4 ML InjectionSY32These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 201720251125
8baba4ea-2855-42fa-9bd9-5a7548d4cec32.4 ML Imfinzi 50 MG/ML InjectionSY32These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 201720251125
8baba4ea-2855-42fa-9bd9-5a7548d4cec3IMFINZI 120 MG in 2.4 ML InjectionPSN32These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 201720251125